Inhibitory effects of Geijigajakyak-Tang on trinitrobenzene sulfonic acid-induced colitis

Journal of Ethnopharmacology

Volumn 126, Issue 2, 2009, Pages 244-251

  Lee, Ji Yun ^a   Kang, Hyo Sook ^a   Park, Byoung Eon ^a   Moon, Hyo Jin ^a   Sim, Sang Soo ^a   Kim, Chang Jong ^a  

^a Chung Ang University   (South Korea)

Author keywords

Geijigajakyak Tang; Malondialdehyde; Muscle contraction; Neutrophil chemotaxis; TNBS induced colitis

Indexed keywords

ATROPINE; CINEOLE; CINNAMALDEHYDE; DEXAMETHASONE; GEIJIGAJAKYAK TANG; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; JUJUBOGENIN; JUJUBOSIDE A; MALONALDEHYDE; MYELOPEROXIDASE; PAEONIFLORIN; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; IC 50; ILEUM CONTRACTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIMARY PREVENTION;

ACROLEIN; ANGIOSPERMS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BENZOIC ACIDS; BRIDGED COMPOUNDS; CHEMOTAXIS; COLITIS; CYCLOHEXANOLS; FEMALE; GLUCOSIDES; GLYCYRRHIZIC ACID; ILEUM; LIPID PEROXIDATION; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MONOTERPENES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NEUTROPHILS; PARASYMPATHOLYTICS; PEROXIDASE; PHYTOTHERAPY; PLANT EXTRACTS; SAPONINS; TRINITROBENZENESULFONIC ACID; TRITERPENES;

FABACEAE; LAURACEAE; MUS; PAEONIA; PAEONIACEAE; RATTUS; RHAMNACEAE; ZINGIBERACEAE; ZIZIPHUS;

EID: 70350336256     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.08.035     Document Type: Article

References (34)

1. Banner K.H., Christophe C., Le Net J.-L., Popovic A., Collins D., and Gale J.D. Macroscopic, microscopic and biochemical characterization of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene. British Journal of Pharmacology 143 (2004) 590-598
2. Barada K.A., Mourad F.H., Sarah I., Khoury C., Safieh-Garabedian B., Nassar C.F., Tawil A., Jurjus A., and Saadé N.E. Up-regulation of nerve growth factor and interleukin-10 in inflamed and non-inflamed intestinal segments in rats with experimental colitis. Cytokines 37 (2007) 236-245
3. Brandtzaeg P., Haraldsen G., and Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Seminal Immunopathology 18 (2007) 555-589
4. Babulka P. Plantes médicinales du traitement des pathologies rheumatismales : de la médicine traditionnelle à la phytothérapie moderne. Phythothérapie 5 (2007) 137-145
5. Chakravarthy B.K., Rao V.Y., Gambhir S.S., and Gode K.D. Isolation of amentoflavone from Selaginella rupestris and its pharmacological activity on central nervous system, smooth muscles and isolated frog heat preparations. Planta Medica 43 (1981) 64-70
6. Chen L.C., Lee M.H., Chou M.H., Lin M.F., and Yang L.L. Pharmacokinetic study paeoniflorin in mice after oral administration of Paeoniae extract. Journal of Chromatography Bulletin 753 (1999) 33-40
7. Chi S.I. Korean-English Translation and Elucidation of Shang Han Lun (2004), Haenglimseowon, Seoul 354-355
8. Cybulsky M.I., McComb D.J., and Movat H.Z. Protein synthesis dependent and independent mechanisms of neutrophil emigration. Different mechanisms of inflammation in rabbits induced by interleukin-1, tumor necrosis factor alpha or endotoxin versus leukocyte chemoattractants. American Journal of Pathology 135 (1989) 227-237
9. Eiserich J.P., Baldus S., Brennan M.-L., Ma W., Zhang C., Tousson A., Castro L., Lusis A.L., Nauseef W.M., White C.R., and Freeman B.A. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296 (2002) 2391-2394
10. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
11. Frevert C.W., Wong V.A., Goodman R.B., Goodwin R., and Martin T.R. Rapid fluorescence-based measurement of neutrophil migration in vitro. Journal of Immunological Methods 213 (1998) 41-52
12. Gan X.L., Hei Z.Q., Huang H.Q., Chen L.X., Li S.R., and Cai J. Effect of Astragalus membranaceus injection on the activity of the intestinal mucosal mast cells after hemorrhagic shock-reperfusion in rats. Clinical Medicine 119 (2006) 1892-1898
13. Gärtner I. Separation of human eosinophils in density gradient of polyvinylpyrrorrhidone-coated silica gel (Percoll). Immunology 40 (1980) 133-138
14. Heading R., Bardhan K., Hollerbach S., Lanas A., and Fisher G. Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome-a European perspective. Alimentary Pharmacology and Therapeutics 24 (2006) 207-236
15. Hong T., Jin G.B., Yoshino G., Miura M., Maeda Y., Cho S., and Cyong J.C. Protective effects of Polygalae root in experimental TNBS-induced colitis in mice. Journal Ethnopharmacology 79 (2002) 341-346
16. Lee J., Kim M.S., Kim E.Y., Park H.J., Chang C.Y., Jung D.Y., Kwon C.H., Joh J.W., and Kim S.J. 15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis. International Immunopharmacology 7 (2007) 1003-1012
17. Liao B.C., Hsieh C.W., Liu Y.C., Tzeng T.T., Sun Y.W., and Wung B.S. Cinnamaldehyde inhibits the tumor necrosis factor-α-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-κB activation: effects upon IκB and Nrf2. Toxicology and Applied Pharmacology 229 (2008) 161-171
18. Li G., Seo C.S., Lee K.S., Kim H.J., Chang H.W., Jung J.S., Song D.K., and Son J.K. Protective constituents against sepsis in mice from the root cortex of Paeonia suffruticosa. Archive of Pharmacological Research 27 (2004) 1123-1126
19. Maity S., Ukil A., Karmakar S., Datta N., Chaudhuri T., Vedasiromoni J.R., Ganguly D.K., and Das P.K. Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. European Journal of Pharmacology 470 (2003) 103-112
20. Morris G.P., Beck P.L., Herridge M.S., Depew W.T., Szewczuk M.R., and Wallace J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 3 (1989) 795-803
21. Nast C.C., and LeDuc L.E. Chemotactic peptides. Mechanism, functions, and possible role in inflammatory bowel disease. Digestive Diseases and Sciences 33 (1988) 50S-57S
22. Neurath M.F., Fuss I., Kelsall B.L., Stuber E., and Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. Journal of Experimental Medicine 182 (1995) 1281-1290
23. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95 (1979) 351-358
24. Paola R.D., Menegazzi M., Mazzon E., Genovese T., Crisafulli C., Bosco M.D., Zou Z., Suzuki H., and Cuzzocrea S. Protective effects of glycyrrhizin in a gut hy Salvatore poxia (ischemia)-reoxygenation (reperfusion) model. Intensive Care Medicine 35 (2009) 687-697
25. Podolsky D.K. Inflammatory bowel disease. New England Journal of Medicine 347 (2002) 417-429
26. Poli E., Lazzaretti M., Grandi D., Pozzoli C., and Coruzzi G. Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis. Neurochemical Research 26 (2001) 1085-1093
27. Quan J.M., Martin T.R., Rosenberg G.B., Foster D.C., Whitmore T., and Goodman R.B. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis. Biochemical and Biophysical Research Communications 219 (1996) 405-411
28. Sandborn W.J., and Targan S.R. Biologic therapy of IBD. Gastroenterology 122 (2002) 1592-1608
29. Sergio M.L., Araceli P.V., and Rachel M. Natural products with calmodulin inhibitor properties. Phytochemistry 68 (2007) 1882-1903
30. Shabalina I., Wiklund C., Bengtsson T., Jacobsson A., Cannon B., and Nedergaard J. Uncoupling protein-1: involvement in a novel pathway for β-adrenergic, cAMP-mediated intestinal relaxation. American Journal of Physiology of Gastrointestinal and Liver Physiology 283 (2002) 1107-1116
31. Stokkers P., and Hommes D. New cytokine therapeutics for inflammatory bowel disease. Cytokine 28 (2004) 167-173
32. Tack J., Fried M., Houghton L.A., Spicaks J., and Fisher G. Systemic review: the efficacy of treatments for irritable bowel syndrome-a European perspective. Alimentary Pharmcacology and Therapeutics 24 (2006) 183-205
33. Van Deventer S.J. Immunotherapy of Crohn's disease. Scandinavia Journal of Immunology 51 (2000) 18-22
34. Van Meeteren M.E., Meijssen M.A.C., and Zijlstra F.J. The effect of dexamethasone treatment on murine colitis. Scandinavia Journal of Gastroenterology 35 (2000) 517-521